Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_02012 |
| Species: | Homo sapiens |
| Position : | chr11:68155000-68173900 |
| Year: | 2025 |
| Title: | Functional variant rs9344 at 11q13.3 regulates CCND1 expression in multiple myeloma with t(11;14). |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 39402215 |
| Tissue: | kidney |
| Tissue Ontology ID: | UBERON:0002113 |
| Cell Source: | HEK293T |
| CVCL ID: | CVCL_0063 |
| Cell Type: | embryonic kidney cell |
| Experiment Type: | Enhancer activity assay, TF binding assay, Functional perturbation assay |
| High Throughput Method: | ChIP-seq; ATAC-seq; RNA-seq; Hi-C |
| Low Throughput Method: | CRISPR Knockout, qRT-PCR; Western blot; CRISPR-Cas9 |
| Target gene : | CCND1 |
| TF name : | PAX5 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| PAX5 | C-MYB transcription factor network | pid | 87 |
| PAX5 | ID | netpath | 38 |